Low-dose dobutamine induces left ventricular mechanical dyssynchrony in patients with dilated cardiomyopathy and a narrow QRS: A study using real-time three-dimensional echocardiography  by Yagishita-Tagawa, Yoshimi et al.
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Aims:  The  effects  of  inotropic  agents  on left ventricular  (LV)  synchrony  in  heart  failure  patients  are  still
unknown.  The  purpose  of  this  study  was  to investigate  the  effects  of  dobutamine  on  LV mechanical
dyssynchrony  and  LV  systolic  performance  in  patients  with  dilated  cardiomyopathy  (DCM)  and  a  narrow
QRS  using  real-time  three-dimensional  echocardiography  (RT3DE).
Methods  and results:  Thirty-three  patients  with  idiopathic  DCM  and  a  narrow  QRS  underwent  low-dose
dobutamine  stress  echocardiography  (LDSE)  with  RT3DE.  A  time-global  LV  volume  curve  and  time-
regional  LV  volume  curves  were  derived  from  RT3DE.  Regional  LV  stroke  volumes  were  summed  in each
stage,  and the  dobutamine-induced  increase  in the sum  of regional  LV  stroke  volumes  was considered
as  the  sum  of regional  contractile  reserve.  Systolic  dyssynchrony  index  (SDI) was  calculated  as  follows:
(standard  deviation  of  time  to  minimal  volume  for  regional  LV  segments)  ×  100/RR  duration.  Among  the
33 patients,  low-dose  dobutamine  increased  global  LV  stroke  volume  (SV)  in  28 (85%), but  decreased
global  LVSV  in  the  remainder  (15%).  The  sum  of  regional  contractile  reserve  was  modestly  correlated
with  the  dobutamine-induced  increase  in  global  LVSV  (R  = 0.57,  p < 0.001).  In  contrast,  low-dose  dobut-
amine  increased  SDI  in  14  (42%)  patients  without  a signiﬁcant  change  in QRS  duration,  and  there  was  an
inverse  correlation  between  the increase  in SDI  and  the  increase  in  global  LVSV  induced  by  dobutamine
(R  = −0.67,  p  <  0.001).
Conclusions:  Dobutamine  may  induce  LV mechanical  dyssynchrony  in  a  substantial  proportion  of  patients
with  DCM  and  a narrow  QRS.  In such  cases,  regional  LV  contractile  reserve  does  not  fully  contribute  to
.
3  Japan increase  in  global  LVSV
© 201
ntroduction
Heart failure patients with low left ventricular (LV) ejection
raction (EF) on optimal medical therapy eventually decompen-
ate and may  need hemodynamic support with inotropic agents
n some cases [1,2]. The positive inotropic agent, dobutamine,
mproves cardiac output through a direct increase in inotropy. In
ontrast, dobutamine may  increase the magnitude of LV mechani-
al dyssynchrony in heart failure patients with a wide QRS [3,4].
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Dobutamine-induced mechanical dyssynchrony could inﬂuence
the inotropic effects of dobutamine and could result in wasted
global cardiac work. Thus, it is important to clarify the effects of
dobutamine on LV mechanical dyssynchrony and LV systolic perfor-
mance in heart failure patients. However, the effects of dobutamine
on LV mechanical dyssynchrony and LV performance in patients
with a narrow QRS are still unknown.
Semiautomated analysis of LV volume using real-time three-
dimensional echocardiography (RT3DE) allows simultaneous
assessment of the time to minimum volume from the global
LV and all LV segments, which is the net result of longitudi-
nal, radial, and circumferential contractile function [5,6]. Thus, it
allows for simultaneous calculation of not only global LV volumet-
ric changes [i.e. global LV stroke volume (SV)], but also regional
LV volumetric changes (i.e. regional LVSV) and the temporal
vier Ltd. All rights reserved.
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ifferences in regional LV volumetric changes (i.e. mechanical
yssynchrony).
The purpose of this study was to investigate the effects of dobut-
mine on LV mechanical dyssynchrony and LV systolic performance
n patients with dilated cardiomyopathy (DCM) and a narrow QRS
sing RT3DE.
ethods
atients
We  prospectively and consecutively enrolled 33 patients with
hronic heart failure and idiopathic DCM selected from those
eferred to our echocardiography laboratory. Inclusion criteria
ere LVEF <40%, normal sinus rhythm <100 beats/min, QRS dura-
ion ≤120 ms,  and no signiﬁcant coronary artery stenosis conﬁrmed
y coronary angiography. We  excluded patients with previous
acemaker implantation, congenital heart disease, or secondary
ardiomyopathy. We  also excluded patients with more than mild
itral regurgitation (regurgitant fraction >30%), more than a trace
mount of aortic regurgitation, other organic valvular disease, or
nadequate echocardiographic image quality. Written informed
onsent to participate in the study was obtained from all subjects.
he study was approved by the Institutional Review Board.
onventional two-dimensional and Doppler echocardiography
With patients in the left lateral decubitus position, conven-
ional two-dimensional (2D) and Doppler echocardiography were
erformed using the iE33 ultrasound system (Philips Healthcare,
othell, WA,  USA) with an S5 transducer. Apical four- and two-
hamber views were acquired for calculation of LVEF using the
iplane method of discs. Mitral regurgitant volume was calculated
s the difference between the mitral inﬂow volume and the left ven-
ricular outﬂow tract SV using the Doppler method [7].  The mitral
egurgitant fraction was calculated as the percentage of mitral
egurgitant volume compared with the mitral inﬂow volume.
eal-time three-dimensional echocardiography
RT3DE uses the iE33 ultrasound machine with an X3-1 trans-
ucer to encompass the entire LV into the RT3DE dataset. A full
olume scan was acquired from an apical window in harmonic
ode from seven R-wave triggered subvolumes during an end-
xpiratory breath-hold. The depth and angle of the ultrasound scan
ector were adjusted to a minimal level that still encompassed
he entire LV at a volume rate of 25–30 s–1. Analyses of RT3DE
atasets were performed with a QLAB workstation using the 3D-
dvanced quantiﬁcation software package (QLAB 3DQ-Advanced,
hilips Healthcare) as described previously [8].  This software uses
ll voxels from RT3DE datasets to perform 3D semiautomated
order detection of LV volume over one cardiac cycle. It uses
 physics-based modeling algorithm that makes no assumptions
egarding LV geometry. LV quantiﬁcation starts by deﬁnition of the
orrect apical four-chamber view with avoidance of LV foreshorten-
ng. After conﬁrmation that the intersection point of the displayed
orizontal and vertical lines is in the middle of the LV cavity, the
nd-diastolic (largest LV volume) phase and end-systolic (smallest
V volume) phase are identiﬁed. On both end-diastolic and end-
ystolic frames, ﬁve identiﬁcation points are sequentially marked:
he inferoseptal, anterolateral, anterior, and inferior mitral annulus,
nd the apex (from either of the two orthogonal long-axis views).
fter this, the software automatically delineates the LV endocar-
ial border from the end-diastolic phase and end-systolic phase
nd LV volumes are calculated from all phases of the cardiac cycle
9]. Then, a global LV volume versus time curve is automatically Cardiology 61 (2013) 275–280
derived. From this curve, end-diastolic volume, end-systolic vol-
ume, global SV (calculated as: end-diastolic volume − end-systolic
volume), and global EF (calculated as: 100 × global SV/end-diastolic
volume) are computed. The LV is divided into 17 segments from
apex to base according to American Heart Association and Ameri-
can Society of Echocardiography segmentation schema, and curves
depicting regional volume over the cardiac cycle are obtained for
each segment [10]. Regional LVSV is calculated from the regional
LV volume versus time curve as the difference between the maxi-
mum  volume and the minimum volume in each of 17 LV segments.
To assess LV mechanical dyssynchrony, the apical cap is excluded
and the temporal disparity of contraction of the 16 other segments
is analyzed. The LV systolic dyssynchrony index (SDI) is calculated
as the standard deviation of time to minimum systolic volume of
the 16 LV segments. SDI is corrected for RR duration and thus dis-
played as a percentage of the RR interval to compensate for heart
rate variability.
Low-dose dobutamine stress echocardiography
All oral medications including beta-blockers were continued
before the study. Dobutamine was infused intravenously for 10-
min  stages at incremental doses of 5 and 10 g/kg/min while
monitoring a single-lead electrocardiogram and noninvasive blood
pressure [11,12].  The test was terminated if any of the fol-
lowing pre-speciﬁed end-points was reached: onset of atrial
ﬁbrillation, >three consecutive ventricular ectopic beats, persis-
tent hemodynamic compromise (fall in the systolic blood pressure
of >20 mmHg), angina, or severe dyspnea. To assess the sum of
regional LV contractile reserve, the apical cap was excluded as well
as the assessment of LV mechanical dyssynchrony. Regional LVSV
in the 16 segments were summed in each stage, and the increase in
sum of regional LVSV from baseline to the peak dose of dobutamine
was considered the sum of the positive responses of different LV
regions to dobutamine (i.e. the sum of regional contractile reserve).
The sum of regional LV contractile reserve is equal to the increase in
global LVSV if LV dyssynchrony does not alter during dobutamine
infusion. In contrast, augmentation of disparity in regional contrac-
tion timing makes the increase in global LVSV smaller than the sum
of regional LV contractile reserve due to the increase in inefﬁcient
regional LV contraction [13].
Statistical analysis
All values are expressed as the mean ± standard deviation.
Changes in parameters between baseline and 10 g/kg/min of
dobutamine infusion were compared with a Wilcoxon signed-
rank test. Differences in parameters between the groups with
and without an increase in global LVSV were compared with
a Mann–Whitney U-test. Correlations were assessed with linear
regression analysis. A p-value < 0.05 was considered to indicate sta-
tistical signiﬁcance.
Results
Baseline characteristics of the study patients are given in Table 1.
Low-dose dobutamine stress echocardiography (LDSE) was fea-
sible in all patients without complications as described above.
Hemodynamic and echocardiographic data at baseline and dur-
ing dobutamine infusion are summarized in Table 2. Heart rate
and systolic blood pressure increased from baseline to dobutamine
infusion. There was  no signiﬁcant change in QRS duration through-
out the study. There was no signiﬁcant change in mitral regurgitant
volume and fraction from baseline to dobutamine infusion. There
was a signiﬁcant increase in LVEF between baseline and dobut-
amine stress (31 ± 6% vs. 39 ± 10%, p < 0.001). LDSE increased global
Y. Yagishita-Tagawa et al. / Journal of
Table  1
Patient characteristics (n = 33).
Baseline variable
Age, years 52 ± 18
Male, % 25 (76)
NYHA functional class II/III 22 (67)/11 (33)
QRS duration, ms 100 ± 12
Medication
Diuretic 30 (91)
Beta-blocker 33 (100)
ACE-inhibitor/ARB 33 (100)
Digoxin 5 (15)
Data are presented as mean ± SD or number (%) of subjects.
ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; NYHA,
New  York Heart Association.
Table 2
Hemodynamic, electrocardiographic, and echocardiographic parameters during
low-dose dobutamine stress echocardiography.
Baseline DOB 10G p-Value
Heart rate, bpm 66 ± 9 78 ± 16 <0.001
Systolic blood pressure, mmHg  121 ± 21 149 ± 32 <0.001
QRS  duration, ms 100 ± 14 99 ± 11 0.45
Doppler method
Mitral regurgitant volume, mL  8 ± 9 12 ± 9 0.063
Mitral regurgitant fraction, % 13 ± 12 14 ± 11 0.71
RT3DE
LV  end-diastolic volume, mL  153 ± 70 150 ± 71 0.86
LV  end-systolic volume, mL 107 ± 55 96 ± 53 0.29
LV  ejection fraction, % 31 ± 6 39 ± 10 <0.05
LV  SV, mL 46 ± 19 55 ± 24 0.098
Cardiac output, L/min 3.0 ± 1.2 4.2 ± 1.8 <0.05
Sum of regional LVSV, mL  55 ± 22 66 ± 29 <0.001
Systolic dyssynchrony index, % 7.3 ± 3.4 7.2 ± 4.5 0.75
D
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L
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b
(
s
r
F
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vata are presented as mean ± SD.
OB 10G, dobutamine 10 g/kg/min; RT3DE, real-time three-dimensional echocar-
iography; LV, left ventricular; SV, stroke volume.
VSV in 28 (85%), and decreased global LVSV in the remainder
15%); however, there was no signiﬁcant change in global LVSV
etween baseline and dobutamine stress in the group as a whole
46 ± 19 mL  vs. 55 ± 24 mL,  p = 0.098). In contrast, LDSE increased
um of regional LVSV in 24 (73%) patients and decreased sum of
egional LVSV in the remainder (27%); there was signiﬁcant change
ig. 1. Changes in increase in 3D global left ventricular stroke volume and increase in th
tress  echocardiography. Correlation between the increase (A) and % increase (B) in 3D glo
olume (i.e. the sum of regional LV contractile reserve) during low-dose dobutamine stre Cardiology 61 (2013) 275–280 277
in sum of regional LVSV between baseline and dobutamine stress
in the group as a whole (55 ± 22 mL  vs. 66 ± 29 mL,  p < 0.001). LDSE
increased SDI in 14 (42%) patients and decreased in the reminder
(58%); there was no signiﬁcant change in SDI between baseline and
dobutamine stress in the group as a whole (7.3 ± 3.4% vs. 7.2 ± 4.5%,
p = 0.75).
There was no signiﬁcant correlation between the QRS  duration
and 3D SDI at baseline (R = 0.16, p = 0.38). There was no signiﬁcant
correlation in dobutamine-induced increase in the QRS duration
and dobutamine-induced increase in SDI (R = 0.13, p = 0.47). Also,
SDI at baseline was  not related to the dobutamine-induced increase
in SDI or the dobutamine-induced increase in global LVSV (R = 0.32,
p = 0.07; R = 0.07, p = 0.98; respectively).
The increase in the sum of regional LVSV (i.e. the sum of
regional contractile reserve) was  modestly correlated with the
dobutamine-induced absolute increase or % increase in global LVSV
derived from RT3DE (R = 0.57, p < 0.001; R = 0.52, p < 0.05, respec-
tively) (Fig. 1). In contrast, there was  an inverse correlation between
the dobutamine-induced increase in SDI and the dobutamine-
induced absolute increase or % increase in global LVSV derived
from RT3DE (R = −0.67, p < 0.001; R = −0.73, p < 0.001; respectively)
(Fig. 2).
An example of a case where dobutamine decreased global LVSV
due to an increased SDI despite an increase in the sum of regional
LVSV is presented in Fig. 3.
Discussion
The present study evaluated the effects of dobutamine infusion
on three-dimensional echocardiographic criteria of LV mechanical
dyssynchrony and global LVSV in patients with DCM and a narrow
QRS. Our results show that LV mechanical dyssynchrony is dynamic
and can be increased by dobutamine infusion in DCM  patients
despite a narrow resting QRS and no signiﬁcant dobutamine-
induced increase in QRS duration. A previous study reported
that some patients with a normal QRS have late LV free-wall
activation relative to the surface QRS [14]. This ﬁnding suggests
that these patients have heterogenous patterns of electrical acti-
vation and may  achieve beneﬁt from cardiac resynchronization
therapy despite a narrow surface QRS. Dobutamine may elicit or
e sum of regional left ventricular (LV) stroke volume during low-dose dobutamine
bal left ventricular (LV) stroke volume and increase in the sum of regional LV stroke
ss.
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Fig. 2. Changes in increase in 3D global left ventricular (LV) stroke volume and the increase in 3D systolic dyssynchrony index during low-dose dobutamine stress echocar-
diography. Correlation between the increase (A) or the % increase (B) in 3D global LV stroke volume and the increase in 3D systolic dyssynchrony index during low-dose
dobutamine stress.
Fig. 3. Real-time three-dimensional echocardiography in a patient with narrow QRS. An example of a case where dobutamine decreased global left ventricular (LV) stroke
volume  (SV) due to an increase in systolic dyssynchrony index (SDI) despite an increase in the sum of regional LVSV. The regional time-volume curves can be derived from
real-time three-dimensional echocardiography (see text) (upper panels). The distribution of regional time to minimum systolic volume can be displayed on a static Bull’s
eye  color map  (lower panels). Each segment is coded according to its time to minimum systolic volume in one of the three basic colors. Segments that reach their minimum
volume  earlier and later are coded in blue-to-green and red-to-yellow, respectively. This patient had little dyssynchrony at rest. However, SDI increased from 2.7% to 14%
w L  to 36
d d-syst
( rred to
e
l
L
e
tith  low-dose dobutamine stress. The patient had a fall in global LVSV from 44 m
obutamine 10 g/kg/min; EDV, end-diastolic volume; EF, ejection fraction; ESV, en
For  interpretation of the references to color in this ﬁgure legend, the reader is refe
mphasize these heterogenous patterns of electrical activation,
eading to an increase in LV mechanical dyssynchrony. In contrast,
V mechanical dyssynchrony can also occur even without LV
lectrical delay when one part of the wall contracts more strongly
han the other [15]. The weaker segment is stretched by the mL, whereas the sum of regional LVSV increased from 43 mL to 56 mL.  DOB 10G,
olic volume; LVSV, left ventricular stroke volume; SDI, systolic dyssynchrony index.
 the web  version of this article.)
stronger segment in systole and does not contract until early
diastole. This early diastolic contraction is also called post-systolic
shortening. Some DCM patients have considerably heterogenous
LV viability [13,16,17].  This heterogeneity of LV viability should
lead to regional post systolic shortening, which may  be induced
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y the inotropic effect of dobutamine. Some previous studies have
hown that LV mechanical dyssynchrony also increases during
xercise in some patients with a normal QRS [18,19].
The most important ﬁnding in the present study was  that
hanges in global LVSV during dobutamine infusion were associ-
ted with changes in LV dyssynchrony as well as changes in the sum
f regional LVSV. There was a positive correlation between changes
n global LVSV and changes in the sum of regional LVSV during
obutamine infusion. In contrast, there was an inverse correlation
etween changes in global LVSV and changes in LV dyssynchrony.
hese results suggest that an increase in LV dyssynchrony partially
ounteracts the dobutamine-induced increase in regional LVSV
i.e. regional contractile reserve) and may  limit the dobutamine-
nduced increase in global LVSV. As a result, global LVSV does
ot increase to the level expected from the increase in sum of
egional LVSV in patients with dobutamine-induced worsening
f LV dyssynchrony (Fig. 1). In general, dobutamine can increase
ontractility in dysfunctional but viable myocardium through beta-
 adrenergic receptor stimulation. Thus, dobutamine is used to
ncrease LVSV in acute heart failure patients. However, it is well
nown that the hemodynamic response to dobutamine can be
nsufﬁcient in some heart failure patients due to oral beta-blockers
12], poorly viable myocardium [20,21],  or the down regulation of
eta-1 adrenergic receptors [22,23]. In addition to these factors,
t should be acknowledged that worsening of LV dyssynchrony as
een in our results may  also be one of the important reasons for
n inadequate response to dobutamine in some acute heart failure
atients. Therefore, we should evaluate the changes in LV mechan-
cal dyssynchrony in acute heart failure patients without adequate
esponses to the inotropic therapy using dobutamine. A previous
tudy reported that in wide QRS patients with left bundle branch
lock, patients with dobutamine-induced increase in septal ﬂash
ailed to demonstrate a dobutamine-induced increase in global
VSV [3].  The present study has shown a similar phenomenon in
arrow QRS patients without a dobutamine-induced increase in
RS duration.
tudy limitations
Several limitations should be acknowledged in the present
tudy. First, this study had a relatively small sample size. Second,
here is concern about the relatively low volume rate (25–30 s–1)
f RT3DE, which may  be insufﬁcient for accurately assessing
V dyssynchrony. However, it is still unclear how high volume
ate is needed for the accurate assessment of LV dyssynchrony
sing RT3DE. Future studies are required to address this issue.
hird, RT3DE does not assess myocardial contractility itself, but
ather endocardial excursion. Myocardial contractility may  need
o be assessed as myocardial shortening or thickening using
train analysis. However, LV global and regional stroke volumes
nd mechanical dyssynchrony can be simultaneously assessed in
T3DE, and this is one of the strengths of RT3DE.
Fourth, all patients in our population took beta-blockers with
 large variety of speciﬁc agents and doses. These beta-blockers
ight weaken inotropic effects of dobutamine, or might have some
nﬂuence on the effects of dobutamine on LV mechanical dyssyn-
hrony. A previous study has shown that beta-blockers can improve
V mechanical dyssynchrony in heart failure patients during long-
erm follow-up [24]. However, the effects of beta-blockers on LV
echanical dyssynchrony during dobutamine infusion are still
ncertain and should be clariﬁed in future studies.Finally, LDSE was performed in patients with stable chronic
eart failure in the present study. As mentioned above, one of the
oals of the present study was to clarify the etiology of differences
n the effects of dobutamine on acute decompensated heart failure. Cardiology 61 (2013) 275–280 279
Future studies including patients with acute decompensated heart
failure will be necessary to address this issue.
Conclusions
Our results derived from RT3DE suggest that dobutamine may
induce LV mechanical dyssynchrony in a substantial proportion of
patients with DCM and a narrow QRS. Furthermore, regional LV
contractile reserve does not fully contribute to an increase in global
LVSV in such cases.
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